Decoding natural protective mechanisms during diapause and longevity to counter aging
Project Number1DP2AG086979-01
Former Number1DP2OD034906-01
Contact PI/Project LeaderSINGH, PARAM PRIYA
Awardee OrganizationUNIVERSITY OF CALIFORNIA, SAN FRANCISCO
Description
Abstract Text
Project Summary/Abstract
Extremophiles—organisms that live in extreme environments—evolve unique adaptations for survival. Extreme
adaptations are easier to measure and characterize than gradual phenotypes. Understanding the regulation of
extreme phenotypes can reveal novel genes and strategies with the potential to bring significant health benefits
to humans. The African turquoise killifish, Nothobranchius furzeri, is an extremophile for survival. This species
lives in ephemeral ponds that completely dry up for up to 8 months each year. They have evolved two
remarkable adaptations to survive in this harsh habitat: a compressed adult lifespan of only 4.5 months and a
form of ‘suspended animation’, whereby embryos can enter diapause and subsist in the mud until the next
rainy season. Diapause embryos already have complex organs and tissues, including muscle, a developing
brain, a heart, and many complex cell types. They can survive in diapause for up to 3 years (~5 times longer
than their adult lifespan) without any detectable trade-off for future life. Thus, diapause is a fascinating state
where the aging clock is paused, and it provides a unique mechanism of long-term protection to a complex
organism. In addition to diapause, we have characterized several killifish species with significant variations in
their lifespans. Significantly long-lived killifish species also have protective mechanisms to slow the aging
clock, providing a unique framework to understand regulators of natural longevity using comparative genomics.
The compressed lifespan and high throughput nature of the turquoise killifish model make them ideal for
functionally validating these regulators and facilitating rapid translation to aging. This project will use an
evolutionary lens equipped with cutting-edge single-cell multi-omics and advanced experimental and statistical
approaches to decode gene regulatory networks during diapause and natural longevity in multiple killifish
species. We will first construct transcriptional regulatory networks at single-cell resolution in diapause to
identify organ-specific regulators of diapause protection. Next, we will develop a novel paradigm to explore
aging by learning from nature’s longevity experiments, which will allow us to decode how long-lived species
maintain their health for a long time and identify the regulators of their longevity. Finally, we will develop novel
approaches to translate these natural protective mechanisms to counter aging. Based on the unique biology of
these extremophile vertebrates, this project will identify entirely new mechanisms that can prolong organ health
during aging in vertebrates and pave the way for novel interventions that can potentially slow aging in humans.
Public Health Relevance Statement
Project Narrative
Aging is the primary risk factor for various diseases, including cancer, heart disease, and neurological
disorders such as Alzheimer’s. Strategies to slow or pause aging have immense potential to delay the onset of
diseases and extend the healthy periods of our lives. In this work, we will study naturally evolved strategies to
slow or pause aging in killifish, identify new genes and pathways for healthy lifespan extension, and pave the
way for future therapeutics to extend human health.
No Sub Projects information available for 1DP2AG086979-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1DP2AG086979-01
Patents
No Patents information available for 1DP2AG086979-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1DP2AG086979-01
Clinical Studies
No Clinical Studies information available for 1DP2AG086979-01
News and More
Related News Releases
No news release information available for 1DP2AG086979-01
History
No Historical information available for 1DP2AG086979-01
Similar Projects
No Similar Projects information available for 1DP2AG086979-01